Methods of controlling T lymphocyte mediated immune responses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 27, 2001
Grant Date -
N/A
app pub date -
Jun 7, 1995
filing date -
May 3, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods and compositions are provided for preventing the development of a T cell mediated autoimmune disease such as Type I diabetes, in which susceptible subjects have T cells sensitized to a disease-related antigen. Subjects are treated by administration of the antigen or fragments thereof to prevent the expansion of the population of sensitized T cells. Alternatively, subjects are treated by administration of immunogenic compositions comprising a mimicry antigen or fragments thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully